GOLGA8B
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
golgin A8 family member B | MIM:609619 | Ensembl:ENSG00000215252 | HGNC:HGNC:31973 | PA142671717 | 15q14 |
GO terms in GOLGA8B
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IBA | GO:0000137 | Golgi cis cisterna |
CC | IBA | GO:0005794 | Golgi apparatus |
CC | IDA | GO:0005794 | Golgi apparatus |
CC | IBA | GO:0005801 | cis-Golgi network |
CC | IDA | GO:0005829 | cytosol |
CC | IBA | GO:0032580 | Golgi cisterna membrane |
CC | IEA | GO:0032580 | Golgi cisterna membrane |
BP | IBA | GO:0007030 | Golgi organization |
BP | IBA | GO:0051225 | spindle assembly |
BP | IBA | GO:0051225 | spindle assembly |
Gene expression in normal tissue: GOLGA8B
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in GOLGA8B
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD177 | Teniposide | 1 |
iGMDRD280 | CYTOCHALASIN B | 3 |
iGMDRD61 | Kinetin riboside | 1 |
iGMDRD57 | Chloropentafluorobenzene | 3 |
iGMDRD316 | N9-Isopropyl-olomoucine | 3 |
iGMDRD446 | LY 2183240 | 3 |
iGMDRD405 | PIK-75 | 3 |
iGMDRD144 | NSC95397 | 4 |
iGMDRD486 | Tosedostat | 1 |
iGMDRD126 | Tipifarnib | 5 |
iGMDRD322 | FK 866 | 3 |
iGMDRD640 | CAY10618 | 3 |
iGMDRD300 | Tozasertib | 1 |
iGMDRD398 | Sepantronium | 5 |
iGMDRD366 | PI-103 | 1 |
iGMDRD329 | Merck60 | 2 |
iGMDRD506 | Fedratinib | 2 |
iGMDRD188 | Piperlongumine | 1 |
iGMDRD100 | Zebularine | 2 |
iGMDRD414 | MST-312 | 3 |
iGMDRD871 | BRD6368 | 2 |
iGMDRD187 | BRD9876 | 1 |
iGMDRD481 | Dactolisib | 1 |
iGMDRD434 | BMS-536924 | 4 |
iGMDRD137 | Indisulam | 3 |
iGMDRD513 | BML-259 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in GOLGA8B